About BELLUS Health (TSE:BLU)
BELLUS Health Inc is a Canada-based biopharmaceutical development company. The Company's pipeline of projects includes the BLU-5937 for chronic cough and several other partnered clinical-stage drug development programs. BLU-5937 is a potent, selective, orally bio-available small molecule antagonist of the P2X3 receptor, a clinically validated target for chronic cough. BLU-5937 has the potential to help a number of chronic cough patients who do not respond to current therapies. BELLUS Health Inc also has economic interests in other partnered clinical-stage drug development programs, including KIACTA for sarcoidosis, AMO-01 for Fragile X Syndrome and ALZ-801 for APOE4 homozygous Alzheimer’s disease.
Industry, Sector and Symbol
Industry Industrial Metals & Minerals
Trailing P/E Ratio-40
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-66.96%
Return on Assets-59.08%
BELLUS Health (TSE:BLU) Frequently Asked Questions
What is BELLUS Health's stock symbol?
BELLUS Health trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BLU."
How were BELLUS Health's earnings last quarter?
BELLUS Health Inc (TSE:BLU) announced its quarterly earnings data on Wednesday, August, 13th. The company reported ($0.02) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.02). The business had revenue of $0.42 million for the quarter, compared to the consensus estimate of $1 million. BELLUS Health had a negative return on equity of 66.96% and a negative net margin of 1,806.45%. View BELLUS Health's Earnings History.
When will BELLUS Health make its next earnings announcement?
Who are some of BELLUS Health's key competitors?
Some companies that are related to BELLUS Health include Newalta (NAL), Geodrill (GEO), Titanium (TIC), Tigers Realm Coal (TIG), Rubicon Minerals (RMX), Platinum Group Metals (PTM), Atico Mining (ATY), Colabor Group (GCL), Canadian Zinc (CZN), Eastern Platinum (ELR), Foraco International (FAR), Duketon Mining (DKM), Energold Drilling (EGD), Golden Queen Mining (GQM), Champion Bear Resources (CBA), Horsehead (ZINCQ), Prospect Global Resources (PGRX) and Bacanora Minerals Ltd Com (BCN).
How do I buy BELLUS Health stock?
Shares of BELLUS Health and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is BELLUS Health's stock price today?
One share of BELLUS Health stock can currently be purchased for approximately C$0.40.
How big of a company is BELLUS Health?
BELLUS Health has a market capitalization of C$47.20 million.
How can I contact BELLUS Health?
BELLUS Health's mailing address is 9-275 Armand-Frappier Blvd, LAVAL, QC H7V 4A7, Canada. The company can be reached via phone at +1-450-6804500.
MarketBeat Community Rating for BELLUS Health (BLU)MarketBeat's community ratings are surveys of what our community members think about BELLUS Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
BELLUS Health (TSE:BLU) Earnings History and Estimates Chart
BELLUS Health (TSE BLU) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/8/2018|| || || || || || || || |
|11/8/2017||Q3 2017||C($0.03)||C$0.09 million||View||N/A|
|5/9/2017||Q1 2017||C$0.02||C$0.01 million||View||N/A|
|3/1/2017||Q4 2016||C($0.02)||C($0.01)||C$0.36 million||View||N/A|
|11/10/2016||Q3 2016||C($0.01)||C($0.01)||C$0.45 million||C$0.36 million||View||N/A|
|8/9/2016||Q2 2016||C($0.01)||C($0.01)||C$0.45 million||C$0.59 million||View||N/A|
|5/12/2016||Q1 2016||C($0.01)||C($0.01)||C$0.40 million||C$0.59 million||View||N/A|
|2/25/2016||Q4 2015||C($0.01)||C$0.02||C$0.80 million||C$2.05 million||View||N/A|
|8/12/2015||Q2 2015||C($0.01)||C($0.01)||C$0.70 million||C$0.59 million||View||N/A|
|11/5/2014||Q3 2014||C($0.02)||C($0.01)||C$0.50 million||C$0.42 million||View||N/A|
|8/13/2014||C($0.02)||C($0.02)||C$1.00 million||C$0.42 million||View||N/A|
|5/7/2014||Q1 2014||C($0.01)||C$0.48 million||View||N/A|
|2/26/2014||Q4 2013||C($0.01)||C$0.75 million||View||N/A|
|11/5/2013||Q3 2013||C$0.02||C$0.53 million||View||N/A|
|8/7/2013||Q2 2013||C($0.02)||C$0.38 million||View||N/A|
|5/15/2013||Q1 2013||C($0.01)||C$0.60 million||View||N/A|
BELLUS Health (TSE:BLU) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for BELLUS Health (TSE:BLU)
No dividend announcements for this company have been tracked by MarketBeat.com
BELLUS Health (TSE BLU) Insider Trading and Institutional Ownership History
BELLUS Health (TSE BLU) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
BELLUS Health (TSE BLU) News Headlines
|BELLUS Health Reports Financial and Operating Results for the Year Ended December 31, 2017|
finance.yahoo.com - February 21 at 11:13 AM
|Bill would mandate greater oversight of health plan mergers|
www.bizjournals.com - February 8 at 5:13 PM
|Canadian Exchanges Stock Scanner, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics|
finance.yahoo.com - January 24 at 8:33 AM
|Research Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita Therapeutics|
finance.yahoo.com - December 26 at 8:56 AM
|BELLUS Health Closes $20M Common Share Financing|
finance.yahoo.com - December 12 at 10:01 AM
|IIROC Trade Resumption - BELLUS Health Inc.|
finance.yahoo.com - December 5 at 10:17 AM
|IIROC Trade Resumption - BLU|
finance.yahoo.com - December 5 at 10:17 AM
|BELLUS Health Announces Overnight Marketed Equity Offering|
finance.yahoo.com - December 4 at 5:14 PM
|BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 14, 2017|
finance.yahoo.com - November 14 at 5:06 PM
|BELLUS Health Reports Financial and Operating Results for the Third Quarter Ended September 30, 2017|
finance.yahoo.com - November 8 at 3:59 PM
|Echo Health Ventures Welcomes Nanette DeTurk and Kent Marquardt to the Company's Advisory Board|
globenewswire.com - October 24 at 11:42 PM
|Bham health care real estate firm expands|
www.bizjournals.com - October 24 at 11:42 PM
|BELLUS Health Inc (BLU) Director Pierre Larochelle Buys 275,000 Shares|
www.americanbankingnews.com - October 3 at 11:16 PM
|BELLUS Health Appoints Dr. Clarissa Desjardins to its Board of Directors|
finance.yahoo.com - October 2 at 12:59 PM
|BELLUS Health (BLUSF) Updates On BLU-5937 & Chronic Cough Key Opinion Leader Event - Slideshow|
seekingalpha.com - September 21 at 4:23 PM
|BELLUS Health Chronic Cough Webcast Taking Place Today|
finance.yahoo.com - September 20 at 5:22 PM
|BRIEF-Bellus Health's BLU-5937 reduces cough without taste disturbance in two preclinical models|
www.reuters.com - September 18 at 4:57 PM
|BELLUS Health's Blu-5937 Significantly Reduces Cough Without Taste Disturbance in Two Preclinical Models|
finance.yahoo.com - September 18 at 4:57 PM
|Report Coverage on Healthcare Stocks, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics|
finance.yahoo.com - September 14 at 5:15 PM
|BELLUS Health to host webcast on chronic cough and treatment approach on September 20, 2017|
finance.yahoo.com - September 6 at 4:38 PM
|BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 15, 2017|
finance.yahoo.com - August 15 at 5:27 PM
|BELLUS Health Reports Financial and Operating Results for the Second Quarter Ended June 30, 2017|
finance.yahoo.com - August 9 at 4:48 PM
|Research Initiated on Healthcare Stocks, BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics|
finance.yahoo.com - August 7 at 5:08 PM
|BELLUS Health, Inc. :BLU-CA: Earnings Analysis: Q1, 2017 By the Numbers : August 4, 2017|
finance.yahoo.com - August 4 at 9:57 PM
|BELLUS Health Inc (BLU) Set to Announce Quarterly Earnings on Tuesday|
www.americanbankingnews.com - August 1 at 7:31 AM
|Roberto Bellini Buys 225,000 Shares of BELLUS Health Inc (TSE:BLU) Stock|
www.americanbankingnews.com - July 18 at 4:18 PM
|BELLUS Health Inc. (BLU.TO)|
finance.yahoo.com - July 9 at 4:29 PM
|BELLUS Health announces closing of the sale of its equity interest in FB Health for total consideration up to CA$2.5M|
finance.yahoo.com - July 3 at 4:39 PM
|Active Wall Street: Research Reports Initiated on Healthcare Stocks BELLUS Health, Helius Medical Technologies, Resverlogix, and Crescita Therapeutics|
www.finanznachrichten.de - June 3 at 5:04 AM
|Bellus posts 1Q profit|
marketbeat.com - May 10 at 5:20 AM
|IIROC Trading Halt - BLU|
www.bizjournals.com - March 1 at 8:49 AM
|Canadian Stocks Are Rising As Brexit Looks Unlikely -- Canadian Commentary|
www.nasdaq.com - June 22 at 8:38 AM
|Savaria, Premium at 52-Week Highs|
www.baystreet.ca - May 5 at 1:43 PM
|Study Reached 120 Qualifying Events, Top-Line Results Expected in Q2 2016|
globenewswire.com - January 21 at 10:13 AM
BELLUS Health (TSE:BLU) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
BELLUS Health (TSE BLU) Stock Chart for Sunday, February, 25, 2018